Polycystin-1 C-terminal tail associates with β-catenin and inhibits canonical Wnt signaling
Open Access
- 16 July 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 17 (20) , 3105-3117
- https://doi.org/10.1093/hmg/ddn208
Abstract
Polycystin-1 (PC1), the product of the PKD1 gene mutated in the majority of autosomal dominant polycystic kidney disease (ADPKD) cases, undergoes a cleavage resulting in the intracellular release of its C-terminal tail (CTT). Here, we demonstrate that the PC1 CTT co-localizes with and binds to β-catenin in the nucleus. This interaction requires a nuclear localization motif present in the PC1 CTT as well as the N-terminal portion of β-catenin. The PC1 CTT inhibits the ability of both β-catenin and Wnt ligands to activate T-cell factor (TCF) -dependent gene transcription, a major effector of the canonical Wnt signaling pathway. The PC1 CTT may produce this effect by reducing the apparent affinity of the interaction between β-catenin and the TCF protein. DNA microarray analysis reveals that the canonical Wnt signaling pathway is activated in ADPKD patient cysts. Our results suggest a novel mechanism through which PC1 cleavage may impact upon Wnt-dependent signaling and thereby modulate both developmental processes and cystogenesis.Keywords
This publication has 40 references indexed in Scilit:
- Polycystin-1 Induces Cell Migration by Regulating Phosphatidylinositol 3-kinase-dependent Cytoskeletal Rearrangements and GSK3β-dependent Cell–Cell Mechanical AdhesionMolecular Biology of the Cell, 2007
- Polycystin-1, STAT6, and P100 Function in a Pathway that Transduces Ciliary Mechanosensation and Is Activated in Polycystic Kidney DiseaseDevelopmental Cell, 2006
- Cystic Renal Neoplasia Following Conditional Inactivation of Apc in Mouse Renal Tubular EpitheliumPublished by Elsevier ,2005
- β-Catenin and Plakoglobin N- and C-tails Determine Ligand SpecificityJournal of Biological Chemistry, 2004
- New insights into ADPKD molecular pathways using combination of SAGE and microarray technologiesGenomics, 2004
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- Aberrant Polycystin-1 Expression Results in Modification of Activator Protein-1 Activity, whereas Wnt Signaling Remains UnaffectedJournal of Biological Chemistry, 2004
- Genetics and Pathogenesis of Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2002
- The Polycystic Kidney Disease 1 Gene Product Mediates Protein Kinase C α-dependent and c-Jun N-terminal Kinase-dependent Activation of the Transcription Factor AP-1Journal of Biological Chemistry, 1998
- c-myc as an inducer of polycystic kidney disease in transgenic miceKidney International, 1991